Product Information

LITHIUM CARBONATE ER 300 MG TB is a generic product labeled by American Health Packaging, priced at $0.1924 per EA under NDC 68084064001. Its NADAC has been published 621 times since Dec 24, 2014.

FDA first approved this application on Oct 28, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LITHIUM CARBONATE ER 300 MG TB

Lithium Carbonate
$0.1924per EA

Strength

300 mg/1

NDC

68084064001

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

LITHIUM CARBONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA076832

FDA Approved

10/28/2004

TE Code

AB

On Market Since

10/13/2014

Pharmacological Classes

Price Statistics

The NADAC for LITHIUM CARBONATE ER 300 MG TB has been published 621 times since Dec 24, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.1924 per EA
All-time high$0.2271 (Nov 13, 2024)
All-time low$0.1260 (Dec 21, 2022)
52-week high$0.2097
52-week low$0.1924
Median price$0.1593
Average price$0.1675
Largest weekly change+33.8% (Jun 19, 2024)
Weeks tracked621
Tracking sinceDec 24, 2014

Price History

1W

0.0%

1M

-2.0%

3M

-3.7%

6M

-5.3%

1Y

-4.0%

3Y

+31.2%

5Y

+24.5%

All

+1.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LITHIUM CARBONATE ER 300 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE ER 300 MG TB, manufactured by American Health Packaging, is $0.1924 per EA (NDC 68084064001), effective Nov 11, 2026.

How has the price of LITHIUM CARBONATE ER 300 MG TB changed over time?

Over the history we have for it, the NADAC for LITHIUM CARBONATE ER 300 MG TB has held within roughly two percent of its current level. It has been tracked across 621 weekly CMS publications since Dec 24, 2014.

What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE ER 300 MG TB?

Since Dec 24, 2014, the NADAC for LITHIUM CARBONATE ER 300 MG TB has ranged from a low of $0.1260 (Dec 21, 2022) to a high of $0.2271 (Nov 13, 2024), with a median of $0.1593 per EA.

Are there cheaper alternatives to LITHIUM CARBONATE ER 300 MG TB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LITHIUM CARBONATE ER 300 MG TB in a comparable dosage form, but none are currently priced below it.

Who manufactures LITHIUM CARBONATE ER 300 MG TB?

LITHIUM CARBONATE ER 300 MG TB (NDC 68084064001) is labeled by American Health Packaging, and CMS classifies it as a generic product.